Yanjuan Liu Selected Research

Yanjuan Liu Research Topics

Disease

6	Sepsis (Septicemia) 01/2024 - 11/2019
5	Neoplasms (Cancer) 01/2024 - 01/2013
3	Inflammation (Inflammations) 02/2024 - 01/2019
3	Exanthema (Rash) 02/2024 - 10/2018
3	Myositis (Idiopathic Inflammatory Myopathies) 08/2019 - 10/2018
2	Breast Neoplasms (Breast Cancer) 03/2024 - 10/2023
2	Dermatomyositis (Dermatopolymyositis) 02/2024 - 01/2021
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2023 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 11/2018
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 11/2018
1	Necrosis 02/2024
1	Muscular Diseases (Myopathy) 02/2024
1	Asphyxia (Suffocation) 06/2023
1	Hypothermia 06/2023
1	Proteinuria 06/2023
1	Heart Arrest (Cardiac Arrest) 06/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	COVID-19 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Amyopathic dermatomyositis 01/2021
1	Cardiotoxicity 01/2021
1	Heart Failure 01/2021
1	Skin Ulcer 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Infections 11/2019
1	Autoimmune Diseases (Autoimmune Disease) 08/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Calcinosis 10/2018
1	Diabetic Cardiomyopathies 10/2014
1	Sarcoma (Soft Tissue Sarcoma) 08/2014
1	Hepatocellular Carcinoma (Hepatoma) 08/2014
1	Lymphatic Metastasis 03/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2014
1	Insulin Resistance 02/2005
1	Type 2 Diabetes Mellitus (MODY) 02/2005
1	Hyperinsulinism (Hyperinsulinemia) 02/2005
1	Atherosclerosis 02/2005

Drug/Important Bio-Agent (IBA)

4	AutoantibodiesIBA 06/2023 - 10/2018
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2018
2	human AZU1 proteinIBA 03/2024 - 10/2023
2	EnzymesIBA 02/2024 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2024 - 08/2021
2	Therapeutic UsesIBA 01/2024 - 06/2023
2	AntioxidantsIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
2	AntibodiesIBA 08/2019 - 10/2018
2	C-Reactive ProteinIBA 08/2019 - 01/2019
2	Creatine Kinase (Creatine Phosphokinase)IBA 08/2019 - 11/2018
2	NucleolinIBA 01/2019 - 10/2014
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 02/2024
1	RNA Splicing FactorsIBA 02/2024
1	Proteoglycans (Proteoglycan)IBA 01/2024
1	Proline (L-Proline)FDA Link 12/2023
1	Arginine (L-Arginine)FDA Link 12/2023
1	XuebijingIBA 12/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 06/2023
1	salicylhydroxamic acid (SHAM)IBA 06/2023
1	Adenosine Triphosphate (ATP)IBA 04/2023
1	fucoidanIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	CollagenIBA 01/2022
1	LipopolysaccharidesIBA 08/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2021
1	xinmailongIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	CEACAM1 ProteinIBA 01/2021
1	Basic-Leucine Zipper Transcription FactorsIBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 11/2019
1	ceritinibIBA 11/2019
1	Matrix Metalloproteinases (MMPs)IBA 08/2019
1	ZincIBA 08/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2019
1	Messenger RNA (mRNA)IBA 08/2019
1	Peptide Hydrolases (Proteases)FDA Link 08/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2019
1	PhosphoproteinsIBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 11/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018
1	Coenzyme A (CoA)IBA 11/2018
1	nuclear matrix protein 2IBA 10/2018
1	SolutionsIBA 08/2014
1	ProdrugsIBA 08/2014
1	isocorydioneIBA 08/2014
1	squamous cell carcinoma-related antigenIBA 03/2014
1	Tumor Biomarkers (Tumor Markers)IBA 03/2014
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013
1	AlkaloidsIBA 01/2013
1	ErbB Receptors (EGF Receptor)IBA 01/2013
1	Insulin (Novolin)FDA Link 02/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2005

Therapy/Procedure

4	Punctures 12/2023 - 11/2019
4	Ligation 12/2023 - 11/2019
2	Therapeutics 06/2023 - 01/2019
1	Induced Hypothermia 06/2023
1	Drug Therapy (Chemotherapy) 03/2014